Even though treating HCC cell lines in vitro with DPP-4 inhibitors failed to suppress cellular proliferation in these studies (20, 21), DPP-4 inhibitor treatment was shown to suppress HCC growth via the infiltration of lymphocytes into xenograft tumors or HCC in vivo (mice). This evidence concerns the gene DPP4 and hepatocellular carcinoma.